BEONE MEDICINES LTD. (ONC) FY2026 YTD Q2 P&L / Income Statement

BEONE MEDICINES LTD. (ONC) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

3,218,509,000 US dollars

Cost of revenue (calculated)

341,745,000 US dollars

Gross profit

2,876,764,000 US dollars

Operating expenses (calculated)

2,301,815,000 US dollars

Income from operations

574,949,000 US dollars

Other income (expense), net (calculated)

negative 3,275,000 US dollars

Income before income taxes

571,674,000 US dollars

Income tax expense

107,310,000 US dollars

Net income

464,364,000 US dollars

Other revenue - Rest of world - total revenue

3,029,000 US dollars

Other revenue - CHINA

13,099,000 US dollars

Other revenue - UNITED STATES

32,231,000 US dollars

Other revenue - Europe - total revenue

3,027,000 US dollars

Product revenue, net - Rest of world - total revenue

138,274,000 US dollars

Product revenue, net - CHINA

964,896,000 US dollars

Product revenue, net - UNITED STATES

1,664,229,000 US dollars

Product revenue, net - Europe - total revenue

399,724,000 US dollars

Cost of sales - product

341,745,000 US dollars

Selling, general and administrative

1,148,311,000 US dollars

Research and development

1,153,504,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.